Do I Have Lyme Disease Quiz

How the Scales are Structured
Who Usually Takes This Test?
See How You Compare
Below is a preview of how scores are typically distributed across each scale.
Example Questions From the Test
- Feverishness, chills, unusual fatigue, or body aches began soon after a confirmed attachment or expanding rash.
- New flu-like symptoms began within days or weeks of plausible outdoor exposure, although I did not see a tick.
- I had mild symptoms, but they began before the possible exposure or had another clear explanation.
- I did not develop a new illness after the possible exposure.
- No visible or unexplained joint swelling.
- Mild puffiness followed a known strain and improved promptly.
- A joint became noticeably swollen or warm without a clear injury, then persisted or returned.
- A joint is markedly swollen, very painful, rapidly worsening, or difficult to bear weight on.
- A familiar mild headache that resolved in my usual way.
- A new or unusual headache that recurs or comes with light sensitivity or neck discomfort.
- No recent headache or unusual neck symptoms.
- A severe or rapidly worsening headache, especially with marked neck stiffness, fever, confusion, or vomiting.
Do I Have Lyme Disease Quiz - Description and methodology of the test
People wondering whether recent outdoor exposure, a rash, flu-like illness, or unexplained nerve, heart, or joint symptoms deserve attention can use the Do I Have Lyme Disease Quiz to organize what they have noticed. It offers a self-reflection result: patterns to document, warning signs to take seriously, and points to discuss with a qualified clinician. Although this Lyme disease quiz organizes reported patterns, it cannot confirm the cause of symptoms.
What This Assessment Explores
The questionnaire organizes experiences into three domains: possible tick exposure and early clues, neurologic or cardiac warning signs, and systemic or musculoskeletal changes. This Lyme quiz helps people review symptoms and decide what to document or discuss.
The result has three summaries:
- Exposure and Early Clues (0-15) indicates No items endorsed (0-0), Context to review (1-2), or Prompt clinical review (3-15).
- Neurologic and Cardiac Warning Signs (0-15) indicates No items endorsed (0), Symptoms to document (1-2), or Prompt assessment (3-15).
- Systemic and Musculoskeletal Symptoms (0-15) indicates No items endorsed (0), Changes to monitor (1-2), or Prompt clinical review (3-15).
Any concerning response matters independently; a low score on one summary cannot rule out Lyme disease or another condition. A single red-flag response takes priority over its scale score, and severe or rapidly worsening symptoms may require urgent or emergency care.
Methodology and Evidence Base
Each item presents four choices covering absent or ordinary explanations, recurring or specific patterns, and severe or urgent experiences. The answer-to-point mapping is not documented, so displayed bands are read as summaries, not probability or severity estimates. Its practical role as a symptom checker for Lyme disease is organizing observations before an appointment.
The questionnaire is conceptually consistent with the Horowitz MSIDS Questionnaire, a multisystem instrument grouping symptoms across bodily systems. The broader MSIDS framework brings exposure, constitutional symptoms, pain, neurologic changes, and cardiac experiences into one clinical picture. It is not identified as that published instrument, so this relationship does not establish an adaptation or validation.
The early Lyme disease symptom study supplies conceptual clinical context for early-symptom items, while the Lyme disease clinical practice guideline supplies external context for warning signs; neither validates this online questionnaire. Displayed bands are unvalidated reflective summaries, not standardized norms or clinical cutoffs. Self-report may reflect recall, current health context, and symptom recognition; record concerning experiences with timing and severity for professional review.
- Citera M, Freeman PR, Horowitz RI. Empirical validation of the Horowitz Multiple Systemic Infectious Disease Syndrome Questionnaire for suspected Lyme disease. International Journal of General Medicine. 2017;10:249-273. 10.2147/IJGM.S140224
- Horowitz RI. Why Can't I Get Better? Solving the Mystery of Lyme and Chronic Disease. New York, NY: St. Martin's Press; 2013.
- Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, Holman MS, Persing DH, Steere AC. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Annals of Internal Medicine. 2002;136(6):421-428. 10.7326/0003-4819-136-6-200203190-00005
- Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Clinical Infectious Diseases. 2021;72(1):e1-e48. 10.1093/cid/ciaa1215
Updated: